NEW AWARD - IMPACT OF GERMLINE GENETIC TESTING FOR MEN WITH PROSTATE CANCER ON ACTIVE SURVEILLANCE, EFFECTIVE 4/1/2020, SIGNED 3/13/2020, DISTRIBUTED 3/17/2020, FAADC 3/17/2020
$2,744,029FY2020Defense Health AgencyDOD
Sloan-Kettering Institute For Cancer Research